|
The Grants Program does not pose limits on the size or duration of the grant request. Each grants request will be assessed based upon its quality, budget, design and impact.
Although research grants for animal health (veterinary) would not fall within the program, concepts involving the use of animal models in research that may have future promise in human therapy and that fall within the Grants Program interest scope would be suitable for submission.
Indirect research costs will be limited to a maximum of 15% of the research costs related to the grants submitted.
Requests from for–profit organizations or research proposals that are commercial in scope will not be considered for review and should not be submitted via the Grants Program.
When reviewing grants applications, the Octapharma grants committee considers the following factors:
1. How high are the intellectual quality and merit of the study?
2. What is its potential impact?
3. How novel is the proposal? (If not novel, to what extend does potential impact overcome this lack? Is the research likely to produce new data and concepts or confirm existing hypothesis?)
4. Is the hypothesis valid and has the applicant presented evidence supporting it?
5. Are the aims logical and realistic?
6. Are the procedures appropriate, adequate and feasible for the research?
7. Are the investigators qualified? Have they shown competence, credentials and experience?
8. Are the facilities adequate and the environment conducive to the research?
9. Overall quality and detail of proposal and research design.
Octapharma is committed to supporting clinical and pre-clinical research projects that promote excellence in patient care and provide valuable information to the medical and patient community that may translate to better management of disease and improvement in patient safety and population health.
To qualify the request for support must relate to clinical or pre-clinical research focusing on human protein therapies in one or more of the following therapeutic areas:
1. Immunotherapy
2. Hematology
3. Intensive Care and Emergency Medicine
1. Grants for general operating expenses, capital building costs
2. Grants for animal health care or research
3. Grants to political, religious, fraternal, discriminatory or for-profit organizations such as pharmaceutical companies, homecare companies, health maintenance organizations, specialty pharmacies and group purchasing organizations
4. Free-of-charge product will not be supplied under the Grants program
5. Charitable donations
6. Continuing education credit fees/tuition, travel or lodging for a healthcare professional to attend an education and/or scientific conference
7. Travel fellowships
8. Programs that do not primarily benefit patient care or advance medical science
9. Requests for grants or donations that are not of a scientific interest to Octapharma
10. Grants requests for organizations or activities outside of the US. For such requests, please contact your local Octapharma office. Contact details can be found at this link.
11. Grants for medical / scientific symposia, professional meetings, continuing education credit fees/tuition, travel or lodging for a healthcare professional to attend an education and/or scientific conference.
Unfortunately, previous support of a program does not guarantee future support. The grants selection process evaluates each grant application and will determine acceptance and level of support for each individual grant request. The requests are not approved until the applicant receives a written confirmation from the Octapharma Grants Committee.
The Octapharma Grant Program can be withdrawn at the discretion of Octapharma USA at any time.
Octapharma will accept grant applications bi-annually during two cycles:
April 1st - September 30th
October 1st - March 31st
Review of all applications received will take place every 6 months - in April/May and October/November. Applicants will be notified in writing of the outcome within 30 days of the completion of the Grant Review process.
|
